Context Therapeutics to Participate in Upcoming Investor Conferences in November
Provided By GlobeNewswire
Last update: Oct 23, 2024
PHILADELPHIA, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing T cell engagers for solid tumors, today announced that the Company will participate in the following investor conferences in November:
Read more at globenewswire.com
